6011000124106~MAPPRIORITY~7

447562003~MAPTARGET~Y84.9

447562003~MAPADVICE~ALWAYS Y84.9 | MAPPED FOLLOWING WHO GUIDANCE

447562003~MAPTARGET~D75.9

6011000124106~MAPPRIORITY~4

900000000000497000~MAPTARGET~XUPkB

6011000124106~MAPRULE~IFA 762315004 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent |

6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA

6011000124106~MAPTARGET~

6011000124106~MAPCATEGORYID~447638001

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO RADIATION CHOOSE T81.89X? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPGROUP~1

6011000124106~MAPGROUP~2

447562003~MAPGROUP~2

6011000124106~MAPTARGET~T80.911?

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO ALKYLATING AGENT CHOOSE T45.1X5S | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~10

447562003~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA

6011000124106~MAPADVICE~IF THERAPY RELATED ACUTE MYELOID LEUKEMIA DUE TO AND FOLLOWING ADMINISTRATION OF ANTINEOPLASTIC AGENT CHOOSE T45.1X5? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~8

6011000124106~MAPRULE~IFA 83250000 | Delayed hemolytic transfusion reaction |

6011000124106~MAPRULE~IFA 127319005 | Anemia due to alloimmune destruction of transfused red cells |

6011000124106~MAPRULE~IFA 766045006 | Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent |

447562003~MAPGROUP~1

6011000124106~MAPRULE~IFA 127319005 | Anemia caused by alloimmune destruction of transfused red cells |

447562003~CORRELATIONID~447561005

6011000124106~MAPADVICE~IF DELAYED HEMOLYTIC TRANSFUSION REACTION CHOOSE T80.911? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPADVICE~IF ANEMIA CAUSED BY ALLOIMMUNE DESTRUCTION OF TRANSFUSED RED CELLS CHOOSE T80.911? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPCATEGORYID~447637006

6011000124106~MAPTARGET~T45.1X5?

6011000124106~MAPTARGET~C92.40

900000000000509007~ACCEPTABILITYID~900000000000548007

447562003~MAPADVICE~ALWAYS D75.9

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO ALKYLATING AGENT CHOOSE D46.9 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF MECHANICAL HEMOLYSIS FOLLOWING INSERTION OF PROSTHETIC HEART VALVE CHOOSE T82.897? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~ALWAYS D75.9

900000000000508004~ACCEPTABILITYID~900000000000548007

447562003~MAPTARGET~

447562003~MAPPRIORITY~1

6011000124106~MAPTARGET~P61.9

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO RADIATION CHOOSE C92.00 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPTARGET~Y71.2

447562003~MAPCATEGORYID~447637006

6011000124106~MAPTARGET~T82.897?

6011000124106~MAPRULE~OTHERWISE TRUE

6011000124106~MAPPRIORITY~5

6011000124106~MAPGROUP~4

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO TOPOISOMERASE TYPE 2 INHIBITOR CHOOSE D46.9 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF ANEMIA DUE TO ALLOIMMUNE DESTRUCTION OF TRANSFUSED RED CELLS CHOOSE T80.911? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPPRIORITY~9

6011000124106~MAPCATEGORYID~447639009

6011000124106~MAPRULE~IFA 1153380009 | Mechanical hemolysis following insertion of prosthetic heart valve |

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO TOPOISOMERASE TYPE 2 INHIBITOR CHOOSE C92.00 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPTARGET~C92.90

6011000124106~MAPTARGET~D59.4

6011000124106~MAPADVICE~IF DIFFERENTIATION SYNDROME DUE TO AND FOLLOWING CHEMOTHERAPY CO-OCCURRENT WITH ACUTE PROMYELOCYTIC LEUKEMIA CHOOSE C92.40 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~ALWAYS T81.89X? | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | EPISODE OF CARE INFORMATION NEEDED | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE

6011000124106~MAPADVICE~IF AGE AT ONSET OF CLINICAL FINDING BEFORE 29.0 DAYS CHOOSE P61.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF THERAPY RELATED ACUTE MYELOID LEUKEMIA DUE TO AND FOLLOWING ADMINISTRATION OF ANTINEOPLASTIC AGENT CHOOSE C92.90 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~1

6011000124106~MAPTARGET~D75.9

6011000124106~MAPTARGET~T45.1X5S

6011000124106~MAPPRIORITY~6

6011000124106~CORRELATIONID~447561005

6011000124106~MAPRULE~IFA 773537001 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia |

6011000124106~MAPRULE~IFA 445518008 &#x7C; Age at onset of clinical finding (observable entity) &#x7C; < 29.0 days

6011000124106~MAPRULE~IFA 766048008 &#x7C; Acute myeloid leukemia and myelodysplastic syndrome related to radiation &#x7C;

6011000124106~MAPTARGET~D46.9

6011000124106~MAPRULE~TRUE

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO RADIATION CHOOSE D46.9 &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPGROUP~3

6011000124106~MAPPRIORITY~3

6011000124106~MAPRULE~IFA 766046007 &#x7C; Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor &#x7C;

6011000124106~MAPADVICE~IF MECHANICAL HEMOLYSIS FOLLOWING INSERTION OF PROSTHETIC HEART VALVE CHOOSE D59.4 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPPRIORITY~2

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO TOPOISOMERASE TYPE 2 INHIBITOR CHOOSE T45.1X5S &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO RADIATION CHOOSE Y84.2 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

447562003~MAPCATEGORYID~447638001

6011000124106~MAPADVICE~IF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME RELATED TO ALKYLATING AGENT CHOOSE C92.00 &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

6011000124106~MAPADVICE~IF DIFFERENTIATION SYNDROME DUE TO AND FOLLOWING CHEMOTHERAPY CO-OCCURRENT WITH ACUTE PROMYELOCYTIC LEUKEMIA CHOOSE T45.1X5? &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT